{{Rsnum
|rsid=4936613
|Chromosome=11
|position=121333892
|Orientation=plus
|GMAF=0.1093
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.9 | 23.2 | 75.9
| HCB | 2.2 | 19.0 | 78.8
| JPT | 1.8 | 15.9 | 82.3
| YRI | 0.0 | 9.5 | 90.5
| ASW | 0.0 | 22.8 | 77.2
| CHB | 2.2 | 19.0 | 78.8
| CHD | 0.0 | 18.5 | 81.5
| GIH | 3.0 | 25.7 | 71.3
| LWK | 0.9 | 15.6 | 83.5
| MEX | 0.0 | 12.3 | 87.7
| MKK | 0.0 | 0.0 | 0.0
| TSI | 2.9 | 16.7 | 80.4
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23006423
  |Trait=Response to taxane treatment (placlitaxel)
  |Title=Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.
  |RiskAllele=
  |Pval=6E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}